Small Molecule Discovery Network And Capabilities

With more than 30 years of experience in small molecule drug discovery, our subject matter experts work as an extension of your team to help accelerate programs from early discovery through clinical development and commercialization. Leveraging best-in-class capabilities across medicinal chemistry, cell biology, computer-aided drug design (CADD), structural biology, and drug metabolism and pharmacokinetics (DMPK), we provide the scientific expertise and integrated support needed to overcome complex development challenges and drive informed decision-making.

Whether you need targeted support in a specific scientific discipline or a fully integrated, multidisciplinary discovery team, Curia offers flexible, high-performance solutions tailored to your program goals. Our collaborative approach, proven track record, and deep technical expertise enable us to efficiently advance promising candidates, reduce development risk, and help transform innovative ideas into successful therapeutic realities.